A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we describe a simple protocol for the isolation and staining of murine bone marrow cells to phenotype hemopoietic stem and progenitor cells along with the supporting niche endothelial and mesenchymal stem cells. A method to enrich cells located in endosteal and central bone marrow areas is also included.
The bone marrow (BM) is the soft tissue found within bones where hematopoiesis, the process by which new blood cells are generated, primarily occurs. As such, it contains hematopoietic stem and progenitor cells (HSPCs), as well as supporting stromal cells that contribute to the maintenance and regulation of HSPCs. Hematological and other BM disorders disrupt hematopoiesis by affecting hematopoietic cells directly and/or through the alteration of the BM niche. Here, we describe a method to study hematopoiesis in health and malignancy through the phenotypic analysis of murine BM HSPCs and stromal niche populations by flow cytometry. Our method details the required steps to enrich BM cells in endosteal and central BM fractions, as well as the appropriate gating strategies to identify the two key niche cell types involved in HSPC regulation, endothelial cells and mesenchymal stem cells. The phenotypic analysis proposed here may be combined with mouse mutants, disease models, and functional assays to characterize the HSPC compartment and its niche.
Flow cytometry is an invaluable method to characterize and prospectively isolate immune and hematopoietic cells. It is also increasingly being used to analyze stromal and epithelial populations of different tissues. The hematopoietic stem cell (HSC) has unique properties of self-renewal and multipotency. In adult mammals, HSCs primarily reside in the bone marrow (BM), where they receive quiescence and survival signals from the surrounding microenvironment or niche1. HSCs are formally defined according to functional assays2. Nevertheless, several landmark papers have shown the usefulness of flow cytometry to identify HSCs....
The animals used in this protocol were housed at the i3S animal facility under specific pathogen-free conditions in a 12 h light-dark cycle and temperature-controlled environment. Free access to standard rodent chow and water was provided. All the animals received humane care according to the criteria outlined by the Federation of European Laboratory Animal Science Associations for the care and handling of laboratory animals (EU Directive 2010/63/EU). The experimental procedure performed on the animals (euthanasia) was a.......
Representative plots of flow cytometry analysis of HSCs and MPPs in a healthy young adult C57Bl/6 mouse are shown in Figure 1. The gating strategy follows the latest harmonizing nomenclature proposed by the ISEH13. When analyzing the impact of a perturbation, such as infection or cancer, it is important to use a control mouse as a reference for normal gates. Fluorescence-minus-one (FMO) controls can be particularly useful to delineate the boundaries of the gates, but .......
While the protocol described is simple and easy to perform, special attention should be brought to specific steps. For example, when obtaining flushed BM (step 5.2), the volume or number of times indicated to pass PBS 2% FBS through the inside of the central part of the bone should not be exceeded, as this might result in significant contamination of the flushed sample by endosteal cell populations.
Alterations to the protocol can be made to facilitate its execution by the investigator. In sam.......
LM was supported by a grant from the Lady Tata Memorial Trust. JR was supported by a PhD fellowship from Fundação para a Ciência e Tecnologia (FCT; FCT fellowship UI/BD/150833/2021). ML was supported by a PhD fellowship from FCT (FCT fellowship 2021.04773.BD). DD was supported by grants from the American Society of Hematology, the Pablove Foundation, FCT (EXPL/MED-ONC/0522/2021), and the Portuguese Society of Hematology. We thank the support from Dr. Catarina Meireles and Emilia Cardoso of TRACY facility at i3s.
....Name | Company | Catalog Number | Comments |
Alexa Fluor 647 anti-mouse CD54/ICAM-1 antibody | BioLegend | 116114 | |
APC Streptavidin | BioLegend | 405207 | |
APC/Cyanine7 anti-mouse CD117 (c-kit) antibody | BioLegend | 105826 | |
APC/Cyanine7 anti-mouse CD45 antibody | BioLegend | 103116 | |
APC/Cyanine7 anti-mouse TER-119/erythroid cells antibody | BioLegend | 116223 | |
Biotin anti-mouse CD3ε antibody | BioLegend | 100304 | |
Biotin anti-mouse CD4 antibody | BioLegend | 100404 | |
Biotin anti-mouse CD8a antibody | BioLegend | 100704 | |
Biotin anti-mouse Ly-6G/Ly-6C (Gr-1) antibody | BioLegend | 108404 | |
Biotin anti-mouse TER-119/erythroid cells antibody | BioLegend | 116204 | |
Biotin anti-mouse/human CD11b antibody | BioLegend | 101204 | |
Biotin anti-mouse/human CD45R/B220 antibody | BioLegend | 103204 | |
Brilliant Violet 510 anti-mouse CD150 (SLAM) antibody | BioLegend | 115929 | |
Calibrite 2 Color Beads | BD Biosciences | 349502 | |
Collagenase IV | Merck Life Science | C1889 | |
Dispase II | Merck Life Science | D4693 | |
Fetal Bovine Serum, qualified, heat inactivated, E.U.-approved, South America Origin | ThermoFisher Scientific | 10500064 | |
Hanks' Balanced Salt Solution (HBSS) | ThermoFisher Scientific | 14175095 | |
Mouse Leptin R Biotinylated Antibody | R&D systems | BAF497 | |
NucBlue Fixed Cell Reagent (DAPI) | ThermoFisher Scientific | R37606 | DAPI reagent |
PE anti-mouse endomucin antibody | ThermoFisher Scientific | 12-5851-82 | |
PE anti-mouse Flk2 (CD135) | ThermoFisher Scientific | 12-1351-82 | |
PE/Cyanine7 anti-mouse CD31 antibody | BioLegend | 102524 | |
PE/Cyanine7 anti-mouse CD48 antibody | BioLegend | 103424 | |
PerCP anti-mouse Ly-6A/E (Sca-1) antibody | BioLegend | 108122 | |
Phosphate-buffered saline (PBS) tablets | Merck Life Science | P4417 | |
Purified anti-mouse CD16/32 antibody | BioLegend | 101302 | |
RBC lysis buffer 10x | BioLegend | 420302 | |
Zombie Violet Fixable Viability Dye | BioLegend | 423114 | fluorescent dye |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved